#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type I Acute respiratory distress syndrome Narcolepsy Ataxia telangiectasia Leber's congenital amaurosis Krabbe's disease Chondrodystrophy Still's disease PIK3CA related overgrowth spectrum Non-small cell lung cancer recurrent B-cell lymphoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Factor IX deficiency Cryoglobulinaemia Factor VIII deficiency More trials…

    Learn about Rare Diseases

    Antisynthetase syndrome Hairy cell leukaemia – Diagnostics Hereditary optic atrophy – Basic Information Chondrosarcoma metastatic – Basic Information Arterial tortuosity syndrome – Diagnostics Inclusion body myositis – Trials in Disease Familial amyotrophic lateral sclerosis – Life with Disease Splenic marginal zone lymphoma Cholangitis sclerosing – Basic Information Glycogen storage disease type V – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    BMS-986365 VERTEPORFIN Fluindione NALDEMEDINE Cldn6 Rna-Lpx Ofloxacin Hydrochloride Etidronate Disodium Roxithromycin Tng462 LUXDEGALUTAMIDE Diclofenac Gskvx000000008885 Mirvetuximab Soravtansine Silibinin Zongertinib Burfiralimab Phleum Pratense Elinzanetant Teprenone Dazostinag More therapies…

    Learn about Your Condition

    Myocardial ischaemia Cholangiosarcoma Arterial disorder Malignant melanoma of eyelid Crohn's disease MELAS syndrome Conjunctivitis Testicular germ cell cancer Mixed dementia Turner's syndrome Naevoid melanoma Body mass index increased Myelofibrosis Vomiting Cystic fibrosis lung More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Skin and Connective Tissue Diseases

  • Study on Dupilumab for Treating Nummular Eczema in Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Dupilumab
    Germany

  • Study on the Safety and Effectiveness of EHSG-KF for Treating Full-Thickness Skin Defects in Adults and Children

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    Italy The Netherlands

  • Study on Preventing Arterial Calcification in Young Patients with Pseudoxanthoma Elasticum Using Etidronate

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Pseudoxanthoma elasticum
    Investigated Drugs:
    • Etidronate Disodium
    The Netherlands

  • Study on EHSG-KF for Treating Partial Deep Dermal and Full Thickness Burns in Adults and Adolescents

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Thermal burn
    Investigated Drugs:
    • Bilayer Engineered Collagen Hydrogel-Based Skin Graft Composed Of Autologous Keratinocytes And Fibroblasts
    The Netherlands

  • Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Bimekizumab
    • Risankizumab
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Skin cancer
    • Basal cell carcinoma
    Investigated Drugs:
    • Balstilimab
    Poland
Previous Page
1 … 65 66 67 68
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!